Afatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that has specific types of abnormal epidermal growth factor receptor (EGFR) genes in patients who haven’t received any treatments for cancer that has already spread to other parts of the body.

This medicine is also used to treat patients with metastatic squamous NSCLC who have received medicines consisting of platinum but did not work well. The medicine is only available with your doctor’s prescription.

The product is available in the following dosing forms:

  1. Tablet